Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: one putt who wrote (620)	4/20/1998 12:13:00 AM
From: Ariella	Read Replies (1) \| Respond to of 1491

Dear Craig -- In answer to your question, I suggest you read these articles from Primary Care Optometry journal. The first gives a very readable account of the decision-making process for doctors who are treating patients with allergic eye problems (see 2nd rung for Opcon-A mention). The second article mentions Pharmos. A wide range of agents is available to fight allergens... slackinc.com Corticosteroids still most effective treatment for ocular inflamma.... slackinc.com Lotemax and Alrex will be a lot easier for patients to deal with who need corticosteroids than others currently on market. --Ariella